CMR-Lupus Comprehensive Approach by Cardiovascular Magnetic Resonance Tomography
NCT03488654 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2018-04-05
Summary
In systemic lupus erythematosus (SLE), cardiac manifestations, e.g. coronary artery disease (CAD) and myocarditis are leading causes of morbidity and mortality. The prevalence of subclinical heart disease in SLE is unknown. We studied whether a comprehensive cardiovascular magnetic resonance (CMR) protocol may be useful for early diagnosis of heart disease in SLE patients without known CAD
Conditions
- Lupus Erythematosus, Systemic
- Coronary Artery Disease
- Myocardial Disease
Interventions
- DIAGNOSTIC_TEST
-
Cardiovascular magnetic resonance
CMR including cine, late gadolinium enhancement (LGE) and stress perfusion sequences
Sponsors & Collaborators
-
University Hospital, Basel, Switzerland
lead OTHER
Principal Investigators
-
Thilo Burkard · University Hospital, Basel, Switzerland
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-07-31
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Uses of CMR in Detection of Left Atrial Thrombus
NCT03662880 ·Status: UNKNOWN ·Phase: NA
-
Myocardial Salvage Assessed by Cardiovascular Magnetic Resonance - Impact on Outcome
NCT00952224 ·Status: COMPLETED
-
CMR in Patients With Myocarditis
NCT01962584 ·Status: COMPLETED
-
Diagnostic Potential of PET/MRI in Cardiac Sarcoidosis
NCT03561025 ·Status: COMPLETED ·Phase: NA
-
Acute Heart Graft Rejection Screening by Cardiac Magnetic Resonance Imaging
NCT02400840 ·Status: WITHDRAWN ·Phase: NA
-
Magnetic Resonance Imaging in Myocarditis
NCT02177630 ·Status: COMPLETED
-
CMR for Prognosis Assessment in NSTEMI
NCT03516578 ·Status: COMPLETED
-
Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
NCT01745237 ·Status: RECRUITING
-
Prevalence of Myocardial Scars on CMR After COVID-19 Infection
NCT04636320 ·Status: COMPLETED ·Phase: NA
-
Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Cardiac Transplant Rejection
NCT01136135 ·Status: COMPLETED
-
Cardiac MRI and Cardiac Allograft Rejection
NCT04311346 ·Status: UNKNOWN
-
The Role of Cardiovascular Magnetic Resonance in Patients With Non-ST- Elevation- Myocardial Infarction
NCT05751057 ·Status: UNKNOWN ·Phase: NA
-
PET MRI Study in Patients With Cardiac Sarcoidosis
NCT03356756 ·Status: COMPLETED
-
Contribution of Cardiac MRI in the Early Diagnosis of Myocarditis Induced by Immunotherapy
NCT05125965 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
CARdiac Imaging and BIomarkers in the Diagnosis of Antibody Mediated Rejection in Heart Transplantation
NCT06774365 ·Status: RECRUITING
-
Aortitis and Retroperitoneal Fibrosis: Evaluation of Diagnostic Criteria
NCT03133949 ·Status: UNKNOWN
-
Performance of Acquisition Automation of Cardiac MRI
NCT06012890 ·Status: UNKNOWN
-
68Ga-NODAGA-RGD PET in Patients With an Occluded Coronary Artery
NCT04871217 ·Status: UNKNOWN ·Phase: NA
-
Tissue and Metabolic Characterization of Arrhythmogenic Cardiomyopathies by Hybrid PET-MRI Imaging, Impact of the Observed Profiles on the Phenotype and on the Evolution of Cardiomyopathy
NCT05450783 ·Status: RECRUITING
-
Non-contrast Enhanced Cardiac Magnetic Resonance Normal Values and Imaging Protocols
NCT01728597 ·Status: RECRUITING
-
Non-invasive Detection of Acute Cell-mediated Graft Rejection in Pediatric Heart Transplant Recipients
NCT06795958 ·Status: RECRUITING
-
Ventricular-arterial Coupling of the Heart Among Patients With Mitral Stenosis Undergoing Percutaneous Trans-luminal Mitral Commissurotomy. Cardiac Magnetic Resonance Study
NCT06054568 ·Status: NOT_YET_RECRUITING
-
Improved Detection of Myocardial Fibrosis: a Cardiovascular Magnetic Resonance Imaging Study
NCT06697509 ·Status: ENROLLING_BY_INVITATION
-
Global CMR Registry
NCT02806193 ·Status: UNKNOWN
-
Characterization of Irreversible Myocardial Injury in Cardiomyopathies by Contrast-enhanced CMR
NCT00549861 ·Status: COMPLETED ·Phase: NA